Among the factors that did not differ significantly between patients who received GCSF and those who did not were age, tumour histology, PS, PD-L1 status, pre-treatment steroid use, pre-treatment NLR, pre-treatment SII and the number of metastatic sites. Here, CD274 is linked to neoplasm.